Takeda Pharmaceutical Company Limited

Other

Watson Pharmaceuticals, Inc.

Andrx Labs, LLC

Actavis, Inc.

Jack Cardinal

Avinash Nangia

Xiu Xiu Cheng

Boyong Li

Dacheng Tian

Unchalee Lodin

Kazuhiro Okochi

A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative and a disintegrating agent is herein disclosed and described. The dosage formulation exhibits a significant increase in bioavailability of the thiazolidinedione derivative component compared to conventional immediate release dosage forms containing only a thiazolidinedione derivative.

The present invention comprises a device and methods for dissolution or immersion testing and, in particular, a device and methods that improve the consistency of test results by limiting the ability of pharmaceutical or other dosage forms to move or reorient during testing.

Dosage form holder device and methods for immersion testing

Growing community of inventors

Tamarac, FL, United States of America

Jack Cardinal